Final answer:
Sedative-hypnotic agents bind to GABA receptors in the brain, which increases the inhibitory effects on neural activity and results in a calming effect.
Step-by-step explanation:
Sedative-hypnotic agents bind to gamma-Aminobutyric acid (GABA) receptors in the brain. These substances, which include drugs such as barbiturates and benzodiazepines, enhance the inhibitory effects of GABA, a neurotransmitter with a quieting effect on neural activity. When these agents activate GABA receptors, they increase the entry of negatively-charged chloride ions into neurons, making them less likely to fire and, thereby, exerting a sedative and calming effect used to treat conditions such as anxiety and insomnia. The binding of sedative-hypnotics to GABA receptors stands in contrast to substances that interact with other neurotransmitter systems, like serotonin and glutamate, which are involved in different neural functions such as mood regulation and excitatory signaling, respectively.